FDA 483 - Barr Laboratories Inc. - April 14, 2017

An FDA inspection of Barr Laboratories, Inc. in Forest, VA, revealed significant deficiencies across multiple systems. Observations included inadequate equipment design and qualification, a lack of environmental monitoring to prevent microbial contamination, and failures in batch production recordkeeping. The findings indicate a moderate level of non-compliance with good manufacturing practices.